Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 440
405 30 Göteborg
0313421000
Fax: +46 31846113

Visiting Address: Medicinaregatan 3, plan 5 , 405 30 Göteborg

Latest publications

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh et al.
International Journal of Virology and AIDS, Journal article 2017
Journal article

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt et al.
Scientific Reports, Journal article 2017
Journal article

Showing 71 - 80 of 149

2010

Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden.
Ola Ghatnekar, Catharina Hjortsberg, Magnus Gisslén, Stefan Lindbäck, Mickael Löthgren
PharmacoEconomics, Journal article 2010
Journal article

2009

Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
Annica Lindkvist, Arvid Edén, Melissa M Norström, Veronica D Gonzalez, Staffan Nilsson et al.
AIDS research and therapy, Journal article 2009
Journal article

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection
Aylin Yilmaz, Magnus Gisslén, S Spudich, E Lee, A Jayewardene et al.
PLoS One, Journal article 2009
Journal article

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals
Aylin Yilmaz, Arash Izadkhasthi, R. W. Price, PW Mallon, M De Meulder et al.
AIDS Research and Human Retroviruses, Journal article 2009
Journal article

Treatment of HIV infection: Swedish recommendations 2009.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström et al.
Scandinavian journal of infectious diseases, Review article 2009
Review article

Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, Patrik Medstrand, Christer Owman et al.
AIDS research and human retroviruses, Journal article 2009
Journal article

The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patients
Filip Josephson, Maria CH Andersson, L. Flamholc, Magnus Gisslén, Lars Hagberg et al.
European Journal Clinical Pharmacology, Journal article 2009
Journal article

Showing 71 - 80 of 149

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?